Watch CRISPR Therapeutics (CRSP) – Baystreet.ca
StockNewsTimes |
Watch CRISPR Therapeutics (CRSP)
Baystreet.ca Just when it looked like CRISPR Therapeutics (NASDAQ: CRSP) would give up all its gains, the stock bounced from $40 at the start of the month to test previous highs. The company benefited from Goldman forecasting 100 percent upside on the stock on Apr … CRISPR Therapeutics (CRSP) Director Sells $5169055.92 in Stock CRISPR Therapeutics (CRSP) Downgraded to “Buy” at BidaskClub CRISPR Therapeutics (NASDAQ:CRSP) Receives New Coverage from Analysts at Goldman Sachs |
